Orchid Pharma Limited

₹886.55As of Sun 8 Nov 2026, 12:00 UTC
NSE:ORCHPHARMAHealthcare
Country India
PE (Fwd) •••
TSR 6Y CAGR 66.79%
Div yield —
ROE 0.64%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.56
PE TTM 152.5
TSR TTM 22.06%
Mkt cap ₹53.09B
ROIC 1.45%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,101
24.23%
0.75%
Hold 0|5|10|11|1
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
16.06
16.94
18.47
18.64
23.59%
16.79%
15.57%
11.93%
Revenue₹B
5.148
5.372
5.232
5.098
(2.85%)
0.16%
(2.60%)
(3.29%)
Peers (US$552.2M)
Cap (US$)
PE
575.6M
26.66x
Capital
TTM
5Y
10Y
Leveragex
5.934
6.983
6.179
EBIT/Intx
2.346
0.367
0.340
Own earn%
(5.13)
(27.48)
(23.11)
Sh yield%
43.34
30.01
31.95
Owners
Insiders/Inst%
5.94
86.00
Short interest%
1.87
SBC / revenue%
0.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
5–12
$1 testx
0.1
Incr. ROIC%
4